Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GalNAc-modified five-component lipid nanoparticles for liver-targeted delivery of p65 siRNA to alleviate cytokine storm in liver injury <i>via</i> NF-κB targeting.

Journal of materials chemistry. B·2026
Same author

Development and validation of an online nomogram for screening metabolic-associated fatty liver disease in obese children.

Italian journal of pediatrics·2025
Same author

Multi-omics evidence supports PROC as a potential predictor of VTE risk: A Mendelian randomization study.

Medicine·2025
Same author

Primary Anterior Mediastinal Cholesterol Granuloma: A Rare Case in a Young Woman and Literature Review.

Current medical imaging·2025
Same author

Tumours in children and adolescents with Turner syndrome and Klinefelter syndrome: a retrospective Chinese cohort study.

BMJ paediatrics open·2025
Same author

Oat β-Glucooligosaccharides: Preparation, characterization, skin permeability, and photodamage repair for skincare applications.

Carbohydrate research·2025

Related Experiment Video

Updated: Dec 27, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

7.0K

Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.

Qing-Shan Li1, Bang-Nian Shen1, Zhen Zhang1

  • 1School of Food and Biological Engineering, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, Hefei University of Technology, Hefei, 230601, China.

Current Medicinal Chemistry
|March 7, 2020
PubMed
Summary

This review highlights 2-pyrazoline derivatives, potent anticancer agents identified since 2010. It explores how structural modifications influence their anticancer activity, offering insights for developing novel cancer therapies.

Keywords:
2-pyrazoline45-dihydro-1H-pyrazoleNitrogencontaining heterocyclic structural unitsSARanticancer activitiesderivativessynthesis

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.9K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.3K

Related Experiment Videos

Last Updated: Dec 27, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

7.0K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.9K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.3K

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • Pyrazole derivatives, specifically 4,5-dihydro-1H-pyrazoles (2-pyrazolines), are five-membered heterocyclic compounds.
  • These compounds exhibit diverse pharmacological activities.
  • Since 2010, significant research has focused on the potent anticancer properties of 2-pyrazoline derivatives.

Purpose of the Study:

  • To review literature on 2-pyrazoline derivatives from 2010 to 2019.
  • To analyze the relationship between structural variations (substituents) on the 2-pyrazoline core and their anticancer activity.
  • To identify key pharmacophore features for designing new anticancer agents.

Main Methods:

  • Comprehensive literature search for studies published between 2010 and 2019.
  • Analysis of reported 2-pyrazoline derivatives and their associated anticancer activities.
  • Structure-activity relationship (SAR) analysis based on substituent modifications.

Main Results:

  • Numerous 2-pyrazoline derivatives have demonstrated significant anticancer potential.
  • Specific substituents on the 2-pyrazoline scaffold are correlated with varying degrees of anticancer efficacy.
  • The review identifies common structural motifs associated with potent anticancer activity.

Conclusions:

  • 2-Pyrazoline derivatives represent a promising scaffold for anticancer drug discovery.
  • Understanding the SAR of these compounds is crucial for rational drug design.
  • Further research into novel substituted 2-pyrazolines could lead to effective new cancer treatments.